Viewing Study NCT05545969


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2025-12-25 @ 8:33 PM
Study NCT ID: NCT05545969
Status: WITHDRAWN
Last Update Posted: 2024-06-26
First Post: 2022-09-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma
Sponsor: Melanoma Institute Australia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module